These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16406571)

  • 1. Translation of an experimental oral vaccine formulation into a commercial product.
    Carter KC; Ferro VA; Alexander J; Mullen AB
    Methods; 2006 Feb; 38(2):65-8. PubMed ID: 16406571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Vaccine Formulation Laboratory: a platform for access to adjuvants.
    Collin N; Dubois PM
    Vaccine; 2011 Jul; 29 Suppl 1():A37-9. PubMed ID: 21684427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
    Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
    Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing DNA vaccines closer to commercial use.
    Carvalho JA; Prazeres DM; Monteiro GA
    IDrugs; 2009 Oct; 12(10):642-7. PubMed ID: 19790015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The development of mucosal vaccines].
    Bakke H; Haneberg B
    Tidsskr Nor Laegeforen; 2006 Nov; 126(21):2818-21. PubMed ID: 17086224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine manufacturing: challenges and solutions.
    Ulmer JB; Valley U; Rappuoli R
    Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency tests of combination vaccines.
    Taffs RE
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S362-6. PubMed ID: 11709774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. This idea worth anything? Mechanics of technology transfer.
    Goodson JM
    J Am Coll Dent; 2006; 73(2):14-7. PubMed ID: 17063895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of vaccines: strengthening the science base.
    Milstien JB
    J Public Health Policy; 2004; 25(2):173-89; discussion 190-6. PubMed ID: 15255384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vaccines: new needs, new possibilities.
    Aziz MA; Midha S; Waheed SM; Bhatnagar R
    Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of globalization on vaccine development and availability.
    Milstien JB; Kaddar M; Kieny MP
    Health Aff (Millwood); 2006; 25(4):1061-9. PubMed ID: 16835187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral vaccination and vaccine-entrapped microparticle delivery system].
    Li FQ; Fei YB; Su H; Hu JH
    Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines under study: non-HIV vaccines.
    Conner K; Wuu A; Maldonado V; Bartlett BL; Tyring SK
    Dermatol Ther; 2009; 22(2):168-85. PubMed ID: 19335728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of nanoparticles/microparticles in mucosal vaccine delivery.
    Vyas SP; Gupta PN
    Expert Rev Vaccines; 2007 Jun; 6(3):401-18. PubMed ID: 17542755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifecycle management for recombinant protein production using mammalian cell culture technology.
    Moran E; Gammell P
    Adv Biochem Eng Biotechnol; 2014; 139():245-56. PubMed ID: 24196316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profit considerations in vaccine safety-related events in China.
    Zhuang J; Lu Y; Wagner AL; Jiang Q
    Expert Rev Vaccines; 2019 Nov; 18(11):1187-1199. PubMed ID: 31674844
    [No Abstract]   [Full Text] [Related]  

  • 20. The next 15 years: taking plant-made vaccines beyond proof of concept.
    Kirk DD; Webb SR
    Immunol Cell Biol; 2005 Jun; 83(3):248-56. PubMed ID: 15877602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.